Novel regulations of the angiotensin II receptor type 1 by calmodulin

被引:6
|
作者
Ehlers, Kevin [1 ]
Clements, Robert [1 ]
VerMeer, Mark [1 ]
Giles, Jennifer [1 ]
Tran, Quang-Kim [1 ]
机构
[1] Des Moines Univ, Osteopath Med Ctr, Dept Physiol & Pharmacol, 3200 Grand Ave,Ryan Hall 258, Des Moines, IA 50312 USA
基金
美国国家卫生研究院;
关键词
Angiotensin II receptor type 1; Calmodulin; Calcium; FRET biosensor; Angiotensin II; SMOOTH-MUSCLE-CELLS; PLASMA-MEMBRANE; BINDING; PROTEINS; NETWORK; PHOSPHORYLATION; INTERACTS; DOMAINS; SYSTEM; KINASE;
D O I
10.1016/j.bcp.2018.03.027
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The angiotensin II receptor type 1 (AT(1)R) mediates many Ca2+-dependent actions of angiotensin II (AngII). Calmodulin (CaM) is a key transducer of Ca2+ signals in cells. Two locations on the receptor's submembrane domains (SMD) 3 and 4 are known to interact with CaM. However, the binding sites for CaM, biochemical properties of the interactions, and their functional impact are not fully understood. Using a FRET-based screening method, we identified a new binding site for CaM on SMD2 (a.a. 125-141), in addition to SMD3 and the juxtamembranous region of SMD4 (SMD4(JM), a.a., 309-327). Simultaneous measurements of CaM binding and free Ca2+ show that the interactions are Ca2+-dependent, with disparate K-d and EC50(Ca2+) values within the physiological range of cytoplasmic Ca2+. Full interaction between CaM and SMD3 requires the entire domain (a.a. 215-242) and has an EC50(Ca2+) value in the range of resting cytoplasmic Ca2+, suggesting AT(1)R-CaM interaction can occur in resting conditions in cells. AngII induces robust ERK1/2 phosphorylation in primary vascular smooth muscle cells. This effect is suppressed by AT(1)R inhibitor losartan and virtually abolished by CaM antagonist W-7. AngII-induced ERK1/2 phosphorylation is suppressed in cells expressing mutant AT(1)R with reduced CaM binding at each identified binding domain. AngII triggers transient Ca2+ signals in cells expressing wild-type AT(1)R. These signals are reduced in cells expressing mutant AT(1)R with reduced CaM binding at SMD3 or SMD4(JM), but are very slow-rising, low amplitude signal in cells expressing AT(1)R. with reduced CaM binding at SMD2. The data indicate that CaM interactions with AT(1)R can occur at various domains, with different affinities, at different physiological Ca2+ levels, and are important for AT(1)R-mediated signaling.
引用
收藏
页码:187 / 200
页数:14
相关论文
共 50 条
  • [41] Selective signal transduction through angiotensin II type 1 receptor induced by angiotensin II
    Miura, SI
    Zhang, JL
    Feng, YH
    Noda, K
    Arakawa, K
    Saku, K
    Karnik, SS
    CIRCULATION, 2001, 104 (17) : 225 - 225
  • [42] Regulation of angiotensin II type 1 (AT1) receptor function
    Thomas, WG
    REGULATORY PEPTIDES, 1999, 79 (01) : 9 - 23
  • [43] Angiotensin III Stimulates Aldosterone Secretion from Adrenal Gland Partially via Angiotensin II Type 2 Receptor But Not Angiotensin II Type 1 Receptor
    Yatabe, Junichi
    Yoneda, Minoru
    Yatabe, Midori S.
    Watanabe, Tsuyoshi
    Felder, Robin A.
    Jose, Pedro A.
    Sanada, Hironobu
    ENDOCRINOLOGY, 2011, 152 (04) : 1582 - 1588
  • [44] Role of angiotensin II type 1 receptor in the regulation of angiogenesis
    Murohara, T
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2003, 35 (11) : A9 - A9
  • [45] The antineoplastic effects of angiotensin II type 1 receptor blockers
    Kapoor, Shailendra
    JOURNAL OF HYPERTENSION, 2013, 31 (01) : 217 - 217
  • [46] Adverse effects of angiotensin II type 1 receptor blockers
    Preobrazhensky, DV
    Sidorenko, BA
    KARDIOLOGIYA, 2002, 42 (03) : 88 - 94
  • [47] Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism
    Meyer, Lucie S.
    Gong, Siyuan
    Reincke, Martin
    Williams, Tracy Ann
    HORMONE AND METABOLIC RESEARCH, 2020, 52 (06) : 379 - 385
  • [48] Translational regulation of the human angiotensin II type 1 receptor
    Elton, TS
    Zhao, X
    Martin, MM
    FASEB JOURNAL, 1999, 13 (07): : A1471 - A1471
  • [49] Angiotensin II type 1A receptor deficiency and longevity
    Nishiyama, Akira
    Matsusaka, Taiji
    Miyata, Toshio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (11) : 3280 - 3281
  • [50] Inhibition of Atherosclerosis by Angiotensin II Type 1 Receptor Antagonists
    Stefan Peters
    American Journal of Cardiovascular Drugs, 2013, 13 : 221 - 224